This statistic shows the average peak sales amount per new pharmaceutical pipeline asset from 2010 to 2019, in million U.S. dollars. In the original study cohort, the average peak sales per asset dropped from 816 million U.S. dollars in 2010 to 376 million U.S. dollars in 2019.
Peak sales for each new pharmaceutical asset from 2010 to 2019, by study cohort
(in million U.S. dollars)
Profit from additional features by authenticating your Admin account
Please authenticate by going to "My account" → "Administration".
Then you will be able to mark statistics as favourites and use personal statistics alerts.
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
Statista Accounts:
Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Single Account
Your perfect start with Statista
Instant access to 1m statistics
Download in XLS, PDF & PNG format
Detailed references
$59$39 / Month *
in the first 12 months
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract; Prices do not include sales tax.
Statistics on "Pharmaceutical industry in the United Kingdom (UK)"
Statista Accounts:
Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.
Deloitte, & GlobalData. (December 10, 2019). Peak sales for each new pharmaceutical asset from 2010 to 2019, by study cohort (in million U.S. dollars) [Graph]. In Statista. Retrieved June 07, 2020, from https://www.statista.com/statistics/825738/peak-sales-for-each-pharmaceutical-asset/
Deloitte, und GlobalData. "Peak sales for each new pharmaceutical asset from 2010 to 2019, by study cohort (in million U.S. dollars)." Chart. December 10, 2019. Statista. Accessed June 07, 2020. https://www.statista.com/statistics/825738/peak-sales-for-each-pharmaceutical-asset/
Deloitte, GlobalData. (2019). Peak sales for each new pharmaceutical asset from 2010 to 2019, by study cohort (in million U.S. dollars). Statista. Statista Inc.. Accessed: June 07, 2020. https://www.statista.com/statistics/825738/peak-sales-for-each-pharmaceutical-asset/
Deloitte, and GlobalData. "Peak Sales for Each New Pharmaceutical Asset from 2010 to 2019, by Study Cohort (in Million U.S. Dollars)." Statista, Statista Inc., 10 Dec 2019, https://www.statista.com/statistics/825738/peak-sales-for-each-pharmaceutical-asset/
Deloitte & GlobalData, Peak sales for each new pharmaceutical asset from 2010 to 2019, by study cohort (in million U.S. dollars) Statista, https://www.statista.com/statistics/825738/peak-sales-for-each-pharmaceutical-asset/ (last visited June 07, 2020)
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.
